Search research articles
Contact Us
Filters
Showing results (31-40 of 50) with videos related to
Page
of 5
Sort By:
Diabetes Research and Clinical Practice
|
March 16, 2019
Acute hyperglycemia increases renal tissue oxygenation as measured by BOLD-MRI in healthy overweight volunteers
Nima Vakilzadeh, Anne Zanchi, Bastien Milani, et al.
Scientific Reports
|
June 14, 2024
Effects of empagliflozin on reproductive system in men without diabetes
Christophe Kosinski, Georgios E Papadakis, Olivier Salamin, et al.
Journal of the American Society of Nephrology : JASN
|
April 7, 2022
Empagliflozin Changes Urine Supersaturation by Decreasing pH and Increasing Citrate
Dusan Harmacek, Menno Pruijm, Michel Burnier, et al.
Swiss Medical Weekly
|
January 18, 2023
Diabetic kidney disease in type 2 diabetes: a consensus statement from the Swiss Societies of Diabetes and Nephrology
Anne Zanchi, Andreas W Jehle, Faiza Lamine, et al.
Frontiers in Cardiovascular Medicine
|
August 14, 2023
Blood pressure and vascular determinants of glomerular filtration rate decline in diabetic kidney disease
Luca Truscello, Dina Nobre, Vehashini Sabaratnam, et al.
Pflugers Archiv : European Journal of Physiology
|
September 17, 2009
Evidence against a direct role of klotho in insulin resistance
Olivier Lorenzi, Christelle Veyrat-Durebex, Claes B Wollheim, et al.
Frontiers in Cardiovascular Medicine
|
April 8, 2022
Twenty-Four Hour Blood Pressure Response to Empagliflozin and Its Determinants in Normotensive Non-diabetic Subjects
Anne Zanchi, Menno Pruijm, Marie-Eve Muller, et al.
Diabetology & Metabolic Syndrome
|
September 27, 2022
Understanding reasons and factors for participation and non-participation to a medication adherence program for patients with diabetic kidney disease in Switzerland: a mixed methods study
Carole Bandiera, Liliane Lam, Isabella Locatelli, et al.
BMJ Open
|
January 14, 2021
Assessing the efficacy and impact of a personalised smoking cessation intervention among type 2 diabetic smokers: study protocol for an open-label randomised controlled trial (DISCGO-RCT)
Carole Clair, Aurélie Augsburger, Priska Birrer, et al.
Revue Medicale Suisse
|
June 1, 2019
[Challenges in managing diabetes in chronic hemodialysis]
Faiza Lamine, Haithem Chtioui, Nora Schwotzer, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 50) with videos related to
Sort By:
Page
of 5
Diabetes Research and Clinical Practice
|
March 16, 2019
Acute hyperglycemia increases renal tissue oxygenation as measured by BOLD-MRI in healthy overweight volunteers
Nima Vakilzadeh, Anne Zanchi, Bastien Milani, et al.
Scientific Reports
|
June 14, 2024
Effects of empagliflozin on reproductive system in men without diabetes
Christophe Kosinski, Georgios E Papadakis, Olivier Salamin, et al.
Journal of the American Society of Nephrology : JASN
|
April 7, 2022
Empagliflozin Changes Urine Supersaturation by Decreasing pH and Increasing Citrate
Dusan Harmacek, Menno Pruijm, Michel Burnier, et al.
Swiss Medical Weekly
|
January 18, 2023
Diabetic kidney disease in type 2 diabetes: a consensus statement from the Swiss Societies of Diabetes and Nephrology
Anne Zanchi, Andreas W Jehle, Faiza Lamine, et al.
Frontiers in Cardiovascular Medicine
|
August 14, 2023
Blood pressure and vascular determinants of glomerular filtration rate decline in diabetic kidney disease
Luca Truscello, Dina Nobre, Vehashini Sabaratnam, et al.
Pflugers Archiv : European Journal of Physiology
|
September 17, 2009
Evidence against a direct role of klotho in insulin resistance
Olivier Lorenzi, Christelle Veyrat-Durebex, Claes B Wollheim, et al.
Frontiers in Cardiovascular Medicine
|
April 8, 2022
Twenty-Four Hour Blood Pressure Response to Empagliflozin and Its Determinants in Normotensive Non-diabetic Subjects
Anne Zanchi, Menno Pruijm, Marie-Eve Muller, et al.
Diabetology & Metabolic Syndrome
|
September 27, 2022
Understanding reasons and factors for participation and non-participation to a medication adherence program for patients with diabetic kidney disease in Switzerland: a mixed methods study
Carole Bandiera, Liliane Lam, Isabella Locatelli, et al.
BMJ Open
|
January 14, 2021
Assessing the efficacy and impact of a personalised smoking cessation intervention among type 2 diabetic smokers: study protocol for an open-label randomised controlled trial (DISCGO-RCT)
Carole Clair, Aurélie Augsburger, Priska Birrer, et al.
Revue Medicale Suisse
|
June 1, 2019
[Challenges in managing diabetes in chronic hemodialysis]
Faiza Lamine, Haithem Chtioui, Nora Schwotzer, et al.
Page
of 5